Video: Big Pharma Psychiatric Drugs Can Kill Your Child 

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles

Video: Big Pharma Psychiatric Drugs Can Kill Your Child  (But all these drugs are FDA-approved so they must be OK. Right?)

“I woke up around 2:30am and realized he should have been home an hour ago. I called his cell phone and it went straight to voicemail. I kept calling and leaving messages for him to answer the phone. I fell asleep and woke up around 6:00am. He wasn’t home. I got ready for work but couldn’t function. I told my boss I had to go home. I got home and the phone was ringing.”

The man on the other end said, “I’m looking for the family of Matthew Steubing.”

I said, “This is his mother, who is this?”

He said, “I’m calling about the jumping.”

The Nightmare of Psychiatric Drugs

Psychiatric drugs are serious business, they have repeatedly been linked to horrible side effects and over 42,000 deaths every year . Unfortunately, psychiatric drugs are also big business . Millions of Americans take them every day and many of them are children. The monsters within the psychiatric and prescription drug industries have sold the American public a box of rocks with fraudulent claims of “chemical imbalances in the brain” that can only be “fixed” with deadly, synthetic mind-altering drugs.

Countless families have been ruined because of lies told by the psychiatric industry. Thousands of lives have been lost because of the “medicines” that were prescribed with ignorance. How many more kids need to die before we all wake up and say enough is enough? When will we no longer accept the bogus accusations that human emotions are indicative of an “imbalance” that needs correction with dangerous mind medicines?

Total Farce

Tests exist to determine physical illness. If a person has cancer, diabetes, or any other disease, a blood test can substantiate the diagnosis. However, ADHD is simply written off as a “chemical imbalance” for which no test exists. Which chemicals? Where? Why can’t it be tested for? Why do we allow for psychiatrists to prescribe dangerous mental medications for children after a brief, 15-minute “consultation” when psychiatrists themselves have this to say about the process:

    “It can be difficult to pick a diagnosis.”

    “Diagnoses are sometimes kind of muddy.”

    “We don’t always make the perfect diagnosis.”

    “It’s hard, we’re wrong about half the time.”

Educate Yourself! You Cannot Rely on Psychiatrists or the Pharmaceutical Industry!

The makers of the award-winning documentaries Making a Killing: The Untold Story of Psychotropic Drugging and The Marketing of Madness: Are We All Insane? have released a new documentary that tells personal stories of loss that have resulted from psychiatric drugs. When you hear what these eight mothers, their families and health experts say, you will be convinced of how wrong psychiatrists are. Visit the Citizen’s Commission on Human Rights website and watch the documentary for free right here:

http://www.cchr.org/videos/dead-wrong.html

Spread the word, share this video with everyone you know. The insanity of handing out mind-medicine like it’s halloween candy must end immediately. The drugging of children is both a maddening and heart breaking issue that’s actively destroying lives, right now.

- Dr. Edward F. Group III, DC, ND, DACBN, DCBCN, DABFM

http://www.globalhealingcenter.com/natural-he...our-child/

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsilor Launches Cutting-Edge 6T Battery for Military Use

Updated Category News Views 1

A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...

Continue Reading
STANLEY Dives Into Flooring: Strategic Move or Risky Bet?

Updated Category News Views 3

STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...

Continue Reading
Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 2

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 2

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

Updated Category News Views 1

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 1

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock Moves Past 3% Stake in Syensqo, Notifications Issued

Updated Category News Views 186

BlackRock Inc. Participation Notification for Syensqo In a noteworthy development, BlackRock Inc. has recently communicated to Syensqo its participation status under Belgian transparency regulations, signaling a significant movement in their share ownership. The company has crossed the crucial 3% threshold, which triggers a notification requirement. Here’s a...

Continue Reading
Exploring the Bullish Trends in D-Wave Quantum's Options Trades

Updated Category News Views 262

Understanding D-Wave Quantum's Options Activity Recently, notable investors have exhibited a strong bullish sentiment towards D-Wave Quantum, signaling confidence in its future performance. When analyzing the options history for D-Wave Quantum (NYSE: QBTS), we identified a total of 21 trades. This activity reveals the mindset of investors which could be crucial for future...

Continue Reading
ECN Capital Moves Forward with Share Buyback Initiatives

Updated Category News Views 67

ECN Capital's Strategic Buyback Plans Approved ECN Capital Corp. (TSX: ECN) has recently received approval from the Toronto Stock Exchange (TSX) to begin normal course issuer bids for its common shares and Series C preferred shares. This strategic decision is aimed at effectively managing the company's equity structure while optimizing its cash resources. Understanding...

Continue Reading
Understanding Recent Updates on Cellectis Voting Rights

Updated Category News Views 130

Significant Updates on Cellectis Share Capital Cellectis is currently navigating through exciting timelines that focus on share capital and voting rights. As a prominent player in the gene editing industry, the company strives diligently to engage with its shareholders and keep them informed about the specifics of its capital structure. Market Listing and Share Details...

Continue Reading
Mallinckrodt plc Reports Strong Q3 Performance and Upgraded Guidance

Updated Category News Views 36

Mallinckrodt plc Financial Highlights Mallinckrodt plc, a global leader in specialty pharmaceuticals, has recently announced its financial outcome for the third quarter of the current fiscal year, demonstrating continued resilience and growth. With net sales reaching $505.5 million, marking a 1.7% increase compared to the same quarter last year, the company has reaffirmed...

Continue Reading